| 2.9 |
14.4 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.7 |
1.7 |
GO:0002859 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.6 |
4.9 |
GO:1990575 |
mitochondrial L-ornithine transmembrane transport(GO:1990575) |
| 1.6 |
14.5 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 1.6 |
4.7 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.3 |
4.0 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.1 |
3.4 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.1 |
3.4 |
GO:2000974 |
negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
| 1.0 |
3.1 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 1.0 |
5.9 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.9 |
4.7 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.9 |
2.6 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.9 |
3.5 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.8 |
2.5 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.8 |
2.5 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.8 |
2.4 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.8 |
2.4 |
GO:0035602 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 0.8 |
4.0 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.8 |
3.9 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.8 |
4.6 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.8 |
5.3 |
GO:0002784 |
regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.7 |
3.0 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.7 |
5.9 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.7 |
0.7 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.7 |
2.1 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.7 |
4.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.7 |
2.0 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.7 |
2.0 |
GO:0070446 |
cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.7 |
2.0 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.7 |
2.0 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.6 |
1.9 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.6 |
0.6 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.6 |
1.9 |
GO:2001190 |
natural killer cell tolerance induction(GO:0002519) positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.6 |
2.5 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.6 |
1.8 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.6 |
1.8 |
GO:0042308 |
negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.6 |
1.8 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.6 |
1.8 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.6 |
1.7 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.6 |
1.7 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.5 |
0.5 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.5 |
3.2 |
GO:0032730 |
positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.5 |
1.6 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.5 |
2.1 |
GO:0009615 |
response to virus(GO:0009615) |
| 0.5 |
0.5 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.5 |
1.5 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.5 |
0.5 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 |
1.5 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.5 |
0.5 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.5 |
2.3 |
GO:0034443 |
negative regulation of lipoprotein oxidation(GO:0034443) |
| 0.5 |
4.5 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.4 |
4.4 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.4 |
3.5 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.4 |
0.9 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.4 |
3.0 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.4 |
1.3 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
| 0.4 |
2.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.4 |
2.1 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.4 |
15.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
1.3 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.4 |
2.1 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.4 |
2.9 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.4 |
0.4 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.4 |
1.2 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.4 |
0.4 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.4 |
1.2 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.4 |
0.8 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.4 |
2.8 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.4 |
1.2 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.4 |
4.8 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.4 |
2.4 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.4 |
1.2 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.4 |
1.9 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.4 |
2.7 |
GO:0008291 |
acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 0.4 |
1.1 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.4 |
1.9 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.4 |
1.1 |
GO:1904640 |
response to methionine(GO:1904640) |
| 0.4 |
1.1 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.4 |
1.1 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.4 |
1.4 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.4 |
1.1 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.3 |
0.7 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.3 |
3.4 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.3 |
3.1 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.3 |
5.8 |
GO:0001660 |
fever generation(GO:0001660) |
| 0.3 |
3.0 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.3 |
0.3 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.3 |
2.0 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 |
2.0 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.3 |
1.7 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
6.0 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 |
1.0 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.3 |
4.3 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.3 |
1.0 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 |
1.6 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.3 |
1.0 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.3 |
1.6 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.3 |
1.3 |
GO:0035419 |
activation of MAPK activity involved in innate immune response(GO:0035419) |
| 0.3 |
2.5 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.3 |
2.2 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 |
0.3 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.3 |
1.9 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.3 |
1.2 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.3 |
7.9 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.3 |
0.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 |
1.2 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.3 |
1.2 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.3 |
2.1 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.3 |
3.3 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
0.9 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.3 |
1.5 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.3 |
0.6 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.3 |
1.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.3 |
0.3 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 0.3 |
1.2 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.3 |
0.9 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.3 |
6.3 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.3 |
0.9 |
GO:0097325 |
melanocyte proliferation(GO:0097325) melanocyte apoptotic process(GO:1902362) |
| 0.3 |
0.3 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
| 0.3 |
1.9 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.3 |
0.6 |
GO:0034165 |
positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.3 |
0.8 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.3 |
0.3 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.3 |
0.8 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.3 |
0.3 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.3 |
1.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
1.9 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.3 |
0.5 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.3 |
0.8 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.3 |
1.1 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
1.6 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 |
1.8 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.3 |
1.8 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.3 |
0.3 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.3 |
0.3 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.3 |
0.5 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.3 |
0.5 |
GO:0002690 |
positive regulation of leukocyte chemotaxis(GO:0002690) |
| 0.3 |
1.3 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 |
0.5 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.2 |
2.2 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.2 |
2.2 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.2 |
3.0 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.2 |
0.5 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.2 |
1.5 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
1.0 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.2 |
0.7 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.2 |
1.2 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.2 |
1.0 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.2 |
1.7 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 |
0.7 |
GO:0021912 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
| 0.2 |
0.5 |
GO:0015872 |
dopamine transport(GO:0015872) |
| 0.2 |
1.9 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.2 |
1.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
0.7 |
GO:0008052 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.2 |
0.7 |
GO:0002728 |
negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.2 |
0.7 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.2 |
0.5 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.2 |
6.0 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.2 |
0.5 |
GO:1901203 |
positive regulation of extracellular matrix assembly(GO:1901203) |
| 0.2 |
0.5 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) |
| 0.2 |
0.7 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.2 |
0.5 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.2 |
2.1 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 |
2.3 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
0.7 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.2 |
0.7 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.2 |
0.9 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
1.4 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.2 |
0.7 |
GO:0051919 |
positive regulation of fibrinolysis(GO:0051919) |
| 0.2 |
0.5 |
GO:0044179 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.2 |
0.7 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
| 0.2 |
2.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.2 |
0.2 |
GO:0043200 |
response to amino acid(GO:0043200) |
| 0.2 |
2.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 |
0.9 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
1.5 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.2 |
0.7 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.2 |
0.7 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.2 |
1.5 |
GO:0098704 |
fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 |
0.7 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.2 |
0.7 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.2 |
1.1 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
5.4 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.2 |
0.2 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.2 |
0.6 |
GO:1990709 |
maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
| 0.2 |
2.3 |
GO:0044821 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.2 |
1.3 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
0.8 |
GO:0060133 |
somatotropin secreting cell development(GO:0060133) |
| 0.2 |
0.4 |
GO:0045667 |
regulation of osteoblast differentiation(GO:0045667) |
| 0.2 |
2.5 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.2 |
1.1 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.2 |
5.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 |
0.6 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.2 |
1.0 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.2 |
1.9 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.2 |
0.6 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 |
0.4 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) |
| 0.2 |
1.4 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.2 |
0.4 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.2 |
1.6 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.2 |
3.7 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
0.2 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.2 |
0.6 |
GO:0009078 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.2 |
1.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
0.4 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.2 |
0.6 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.2 |
0.2 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.2 |
0.8 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.2 |
0.6 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
0.2 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.2 |
1.6 |
GO:0033029 |
regulation of neutrophil apoptotic process(GO:0033029) |
| 0.2 |
0.6 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.2 |
2.0 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 |
0.6 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.2 |
0.6 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.2 |
0.6 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.2 |
0.8 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 |
2.7 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.2 |
0.6 |
GO:0043315 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.2 |
0.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
1.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
0.4 |
GO:0090306 |
spindle assembly involved in female meiosis(GO:0007056) spindle assembly involved in meiosis(GO:0090306) |
| 0.2 |
1.0 |
GO:1900106 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.2 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 |
0.8 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.2 |
1.7 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
1.1 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.2 |
1.1 |
GO:0048489 |
synaptic vesicle transport(GO:0048489) synaptic vesicle localization(GO:0097479) establishment of synaptic vesicle localization(GO:0097480) |
| 0.2 |
4.5 |
GO:0016024 |
CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.2 |
2.6 |
GO:0033034 |
positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.2 |
0.7 |
GO:0070893 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.2 |
1.3 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 |
0.7 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 |
0.4 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 0.2 |
3.6 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 |
0.9 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.2 |
0.4 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.2 |
1.8 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.2 |
0.7 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.2 |
3.6 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.2 |
0.2 |
GO:0014870 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
| 0.2 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
0.5 |
GO:0046495 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.2 |
0.7 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 |
0.3 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.2 |
0.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.2 |
0.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
0.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 |
3.1 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.2 |
1.0 |
GO:0060681 |
branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
0.9 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.2 |
1.0 |
GO:0042531 |
positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.2 |
0.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
0.5 |
GO:0048242 |
regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) epinephrine secretion(GO:0048242) |
| 0.2 |
1.5 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.2 |
4.5 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.2 |
1.3 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.2 |
0.2 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.2 |
1.5 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 |
0.3 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
0.2 |
GO:0002583 |
regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
| 0.2 |
0.3 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.2 |
0.7 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.2 |
0.3 |
GO:0035905 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.2 |
0.5 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.2 |
1.3 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.2 |
2.1 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.2 |
1.8 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
2.9 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.2 |
0.5 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.2 |
0.2 |
GO:0051402 |
neuron apoptotic process(GO:0051402) |
| 0.2 |
0.5 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 0.2 |
0.3 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.2 |
0.5 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
0.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
0.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
0.8 |
GO:0006696 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 |
0.5 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.2 |
0.2 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.2 |
0.8 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 |
0.2 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 |
0.3 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.2 |
1.1 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.2 |
0.5 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.2 |
0.3 |
GO:0071864 |
regulation of cell proliferation in bone marrow(GO:0071863) positive regulation of cell proliferation in bone marrow(GO:0071864) |
| 0.2 |
1.4 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.2 |
1.7 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.2 |
0.6 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.2 |
4.7 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 |
1.0 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.1 |
0.6 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.6 |
GO:0019859 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.1 |
0.9 |
GO:0035437 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 |
0.6 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
3.2 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.1 |
1.0 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
2.3 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.1 |
0.6 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 |
1.0 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
5.5 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.1 |
2.0 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.7 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.3 |
GO:0032764 |
negative regulation of mast cell cytokine production(GO:0032764) negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
| 0.1 |
0.1 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
0.6 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 |
0.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.1 |
1.7 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.1 |
0.4 |
GO:0002793 |
positive regulation of peptide secretion(GO:0002793) |
| 0.1 |
2.7 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
1.6 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.1 |
GO:1902218 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 0.1 |
0.3 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.4 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
3.3 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.1 |
GO:0044266 |
multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.1 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.6 |
GO:1903121 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.7 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.1 |
0.6 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.1 |
0.3 |
GO:0071623 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.1 |
0.1 |
GO:0046782 |
regulation of viral transcription(GO:0046782) |
| 0.1 |
1.1 |
GO:0043585 |
nose morphogenesis(GO:0043585) |
| 0.1 |
0.4 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 |
1.0 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.1 |
1.2 |
GO:2000553 |
positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.1 |
2.7 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.1 |
0.4 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.5 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.1 |
0.7 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 |
1.4 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
0.3 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 |
0.7 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 |
0.1 |
GO:0014901 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 0.1 |
1.1 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.5 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
1.6 |
GO:0043407 |
negative regulation of MAP kinase activity(GO:0043407) |
| 0.1 |
0.4 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 |
0.8 |
GO:0030421 |
defecation(GO:0030421) |
| 0.1 |
0.4 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.1 |
1.2 |
GO:0051897 |
positive regulation of protein kinase B signaling(GO:0051897) |
| 0.1 |
2.4 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.7 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
0.5 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.4 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
1.7 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
1.8 |
GO:0032732 |
positive regulation of interleukin-1 production(GO:0032732) |
| 0.1 |
0.3 |
GO:0071655 |
granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.1 |
0.5 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.1 |
0.4 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.4 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.1 |
0.7 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.1 |
0.8 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.9 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.6 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.4 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.1 |
0.9 |
GO:0035272 |
exocrine system development(GO:0035272) |
| 0.1 |
0.8 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.1 |
0.3 |
GO:0038179 |
neurotrophin signaling pathway(GO:0038179) |
| 0.1 |
0.6 |
GO:0050755 |
chemokine metabolic process(GO:0050755) |
| 0.1 |
0.1 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.1 |
0.4 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
1.1 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 |
0.5 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.1 |
0.8 |
GO:0019229 |
regulation of vasoconstriction(GO:0019229) |
| 0.1 |
0.5 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
1.0 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.1 |
2.0 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) |
| 0.1 |
0.5 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.1 |
0.2 |
GO:0072034 |
renal vesicle induction(GO:0072034) |
| 0.1 |
1.9 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.2 |
GO:0098743 |
cell aggregation(GO:0098743) |
| 0.1 |
0.1 |
GO:0006705 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.1 |
1.0 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.9 |
GO:0071725 |
toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.1 |
4.5 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 |
1.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.4 |
GO:0080121 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 |
0.4 |
GO:0070175 |
positive regulation of enamel mineralization(GO:0070175) |
| 0.1 |
0.1 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.1 |
0.4 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
0.2 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.1 |
0.5 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.1 |
0.5 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
3.7 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.4 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.8 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.5 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.1 |
1.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.7 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
1.2 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
2.6 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.2 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.1 |
GO:0046113 |
nucleobase catabolic process(GO:0046113) |
| 0.1 |
0.3 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 |
0.5 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 |
1.3 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.7 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 |
1.9 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.1 |
4.0 |
GO:0060512 |
prostate gland morphogenesis(GO:0060512) |
| 0.1 |
0.1 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 |
2.0 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.1 |
GO:0016071 |
mRNA metabolic process(GO:0016071) |
| 0.1 |
3.2 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.1 |
0.2 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.1 |
0.7 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.1 |
0.4 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 |
1.1 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.3 |
GO:1904579 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.1 |
0.4 |
GO:0010513 |
positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.1 |
0.3 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 |
0.4 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
2.4 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.1 |
1.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 |
0.3 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.1 |
0.3 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.1 |
0.3 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
1.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.4 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.2 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.1 |
0.4 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.7 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.1 |
1.4 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 |
0.8 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.1 |
1.6 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.4 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.3 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
0.1 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.1 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.1 |
0.9 |
GO:0046087 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.3 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.1 |
0.5 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.1 |
3.1 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
1.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.4 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.1 |
0.3 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.1 |
0.5 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.1 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.1 |
1.7 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
1.0 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
0.2 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.1 |
0.7 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.5 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.1 |
0.3 |
GO:0046463 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 |
1.0 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.5 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 |
0.8 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.7 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 |
0.4 |
GO:0071462 |
cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.1 |
0.5 |
GO:0052250 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 |
0.5 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.1 |
0.4 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.1 |
1.1 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.1 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.1 |
0.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
2.9 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.3 |
GO:1900075 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.1 |
0.3 |
GO:0071901 |
negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 |
0.7 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 |
0.4 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.1 |
0.4 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.5 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 |
0.7 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 |
6.9 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.3 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 |
0.7 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.5 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.1 |
0.8 |
GO:0060315 |
negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.1 |
2.0 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.3 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.1 |
0.3 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.1 |
0.5 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
0.8 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.7 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
6.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.3 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.3 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.1 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.1 |
1.0 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
0.7 |
GO:0015727 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 |
0.9 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.4 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.1 |
1.8 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.3 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.1 |
0.3 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.1 |
0.8 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.4 |
GO:0097156 |
fasciculation of motor neuron axon(GO:0097156) |
| 0.1 |
0.2 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.4 |
GO:0070350 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.1 |
5.0 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.1 |
0.1 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
1.0 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
0.5 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.5 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
1.0 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.8 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.1 |
0.8 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.1 |
0.7 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.3 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
0.3 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.2 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.4 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 |
0.3 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 |
0.6 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.2 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.1 |
2.1 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.1 |
0.9 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 |
1.0 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
1.1 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
0.5 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
0.2 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 |
0.5 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
0.5 |
GO:0001501 |
skeletal system development(GO:0001501) |
| 0.1 |
0.3 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) |
| 0.1 |
0.5 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
0.3 |
GO:0032827 |
negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 0.1 |
2.5 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.4 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 |
0.4 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 |
0.7 |
GO:0098706 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 |
0.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.7 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.8 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.3 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 |
2.1 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
0.3 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.3 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.1 |
1.1 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.2 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.1 |
0.4 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.6 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
0.1 |
GO:0000717 |
nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.1 |
2.0 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.5 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.5 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
1.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.1 |
0.6 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
2.1 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.3 |
GO:1902159 |
regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.1 |
1.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.9 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.4 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
0.3 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.6 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.3 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.1 |
0.5 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.3 |
GO:1903964 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.5 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.1 |
0.3 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.1 |
0.5 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.1 |
1.6 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.2 |
GO:0031529 |
ruffle organization(GO:0031529) ruffle assembly(GO:0097178) |
| 0.1 |
0.2 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.1 |
0.2 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.1 |
1.2 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.4 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.1 |
0.2 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
3.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.4 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.1 |
0.2 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.1 |
1.5 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.2 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
0.2 |
GO:0090274 |
regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 |
0.9 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.1 |
0.8 |
GO:0097106 |
postsynaptic density organization(GO:0097106) |
| 0.1 |
1.1 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.1 |
2.8 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.7 |
GO:0042424 |
phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.1 |
0.4 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.7 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.1 |
0.2 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.6 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
0.4 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.1 |
0.9 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.1 |
0.2 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.1 |
0.5 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.8 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.2 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.1 |
0.1 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 |
0.2 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.1 |
0.8 |
GO:0006636 |
unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.1 |
0.2 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.1 |
0.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
2.4 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.4 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.8 |
GO:0090520 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
0.8 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.1 |
0.8 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.8 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.2 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.1 |
0.3 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.2 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.8 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.2 |
GO:0032096 |
regulation of response to food(GO:0032095) negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
0.8 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.1 |
0.1 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.1 |
0.7 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.4 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.7 |
GO:0060563 |
neuroepithelial cell differentiation(GO:0060563) |
| 0.1 |
0.1 |
GO:0060965 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 |
0.1 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.1 |
2.1 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 |
0.1 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.1 |
0.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.1 |
0.4 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.1 |
GO:1903795 |
regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.1 |
0.4 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.9 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
0.3 |
GO:1903039 |
positive regulation of homotypic cell-cell adhesion(GO:0034112) positive regulation of leukocyte cell-cell adhesion(GO:1903039) |
| 0.1 |
0.1 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.1 |
0.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 |
0.9 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
0.8 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.5 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.1 |
1.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 |
1.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.2 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
1.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.1 |
GO:0007389 |
pattern specification process(GO:0007389) |
| 0.1 |
0.3 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.1 |
0.6 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.1 |
0.4 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.1 |
0.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.1 |
0.1 |
GO:0051646 |
mitochondrion localization(GO:0051646) |
| 0.1 |
0.1 |
GO:0045402 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.1 |
0.1 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
0.5 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.6 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
15.0 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.2 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.3 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.1 |
0.3 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.1 |
1.4 |
GO:0001649 |
osteoblast differentiation(GO:0001649) |
| 0.1 |
0.5 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.1 |
0.2 |
GO:2000909 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 |
0.6 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 |
1.6 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.1 |
0.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.3 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.1 |
1.3 |
GO:0070571 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 |
0.6 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.1 |
1.4 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.2 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.1 |
0.3 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 |
0.2 |
GO:2000282 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of cellular amino acid metabolic process(GO:0045763) negative regulation of adrenergic receptor signaling pathway(GO:0071878) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) regulation of cellular amino acid biosynthetic process(GO:2000282) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.1 |
2.3 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.3 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.3 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.1 |
0.9 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
0.6 |
GO:0001763 |
morphogenesis of a branching structure(GO:0001763) |
| 0.1 |
0.3 |
GO:1903045 |
neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
| 0.1 |
0.3 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.1 |
0.3 |
GO:0032373 |
positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
| 0.1 |
0.2 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
0.5 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.5 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.1 |
6.7 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.9 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 |
0.2 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.1 |
2.6 |
GO:0014072 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.1 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.1 |
0.4 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.1 |
0.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
1.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.1 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.1 |
1.8 |
GO:0006555 |
methionine metabolic process(GO:0006555) |
| 0.1 |
1.8 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.4 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.6 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.3 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.1 |
GO:0008628 |
hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.1 |
0.2 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.1 |
0.2 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.1 |
0.5 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.7 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.7 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.3 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.1 |
0.4 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.3 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
0.2 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.1 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
1.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 |
0.8 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.3 |
GO:1903844 |
regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
| 0.1 |
0.2 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.6 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.1 |
0.2 |
GO:0033967 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.1 |
0.1 |
GO:0044793 |
negative regulation by host of viral process(GO:0044793) |
| 0.1 |
0.2 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.1 |
1.3 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
9.5 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.3 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.1 |
0.7 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.1 |
0.5 |
GO:1901299 |
negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
| 0.1 |
0.2 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 |
0.8 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
1.7 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.2 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
1.3 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 |
0.3 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 |
0.3 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
1.9 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.6 |
GO:0002483 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
| 0.1 |
1.0 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.1 |
1.0 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
1.0 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.1 |
1.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.1 |
0.5 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.3 |
GO:1902462 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.1 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
0.7 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.2 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.1 |
0.2 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.1 |
0.6 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.6 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
0.3 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
1.0 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.2 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.1 |
0.2 |
GO:0003340 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.1 |
0.2 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
1.1 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.7 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.3 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
0.2 |
GO:0048200 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.1 |
0.3 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
0.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.3 |
GO:0019627 |
urea metabolic process(GO:0019627) |
| 0.1 |
1.7 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.1 |
0.9 |
GO:0006366 |
transcription from RNA polymerase II promoter(GO:0006366) |
| 0.1 |
0.4 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
0.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.2 |
GO:0010898 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
0.2 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
1.5 |
GO:0003298 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.2 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.5 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.1 |
0.1 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.1 |
0.1 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.1 |
0.3 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.1 |
1.0 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.1 |
0.6 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.2 |
GO:0071352 |
interleukin-2-mediated signaling pathway(GO:0038110) cellular response to interleukin-2(GO:0071352) |
| 0.1 |
2.6 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.2 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.1 |
0.2 |
GO:0036060 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.1 |
0.2 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 |
0.2 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.3 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.1 |
0.3 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.1 |
0.5 |
GO:0036503 |
ERAD pathway(GO:0036503) |
| 0.1 |
0.5 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
0.2 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.3 |
GO:0046949 |
fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.0 |
0.2 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 |
0.2 |
GO:1902400 |
signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 |
0.3 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 |
0.2 |
GO:0033384 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) farnesyl diphosphate metabolic process(GO:0045338) |
| 0.0 |
0.0 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
2.6 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
1.9 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.0 |
3.5 |
GO:0060337 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.3 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 |
0.2 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
0.4 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.0 |
0.2 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.1 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.0 |
0.1 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.0 |
1.3 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.0 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 0.0 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.3 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 0.0 |
0.3 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.2 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.1 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.0 |
2.3 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.0 |
0.1 |
GO:0036135 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.0 |
0.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.0 |
0.2 |
GO:0009071 |
L-serine catabolic process(GO:0006565) serine family amino acid catabolic process(GO:0009071) |
| 0.0 |
0.1 |
GO:0051085 |
'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.9 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.3 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.3 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.0 |
0.1 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.0 |
0.8 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.1 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.0 |
0.2 |
GO:0006489 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.0 |
0.3 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.1 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.4 |
GO:0032092 |
positive regulation of protein binding(GO:0032092) |
| 0.0 |
0.3 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.0 |
0.5 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 |
1.1 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
2.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.6 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.2 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.0 |
0.3 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
| 0.0 |
0.7 |
GO:0003299 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
1.3 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 |
0.4 |
GO:0061072 |
iris morphogenesis(GO:0061072) |
| 0.0 |
0.5 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.0 |
GO:0036367 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 |
0.3 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.0 |
0.2 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.2 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.2 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.0 |
0.4 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.2 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.2 |
GO:0002305 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.0 |
0.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.0 |
0.3 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.4 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.3 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.0 |
0.5 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.3 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.0 |
1.2 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.5 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.0 |
0.4 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.1 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
0.4 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.0 |
0.0 |
GO:0002883 |
hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
| 0.0 |
0.9 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 |
0.1 |
GO:0071799 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 |
0.1 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.2 |
GO:0046498 |
S-adenosylmethionine cycle(GO:0033353) S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.4 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 |
0.2 |
GO:0071900 |
regulation of protein serine/threonine kinase activity(GO:0071900) |
| 0.0 |
0.3 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.8 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.0 |
GO:0060916 |
mesenchymal cell proliferation involved in lung development(GO:0060916) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.0 |
0.6 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.2 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.2 |
GO:0045766 |
positive regulation of angiogenesis(GO:0045766) |
| 0.0 |
0.4 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.1 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 |
0.8 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.1 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.0 |
0.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.0 |
0.7 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
1.0 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.0 |
GO:0042222 |
interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 |
0.3 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.0 |
0.1 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.0 |
0.5 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.6 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.9 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.2 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.1 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.0 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
0.4 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.1 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.0 |
0.8 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.1 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.0 |
0.2 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.9 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.8 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.0 |
0.4 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.4 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.4 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.0 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.3 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.5 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.3 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.0 |
0.3 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.1 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.0 |
0.1 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.0 |
1.2 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.1 |
GO:0014062 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.2 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.4 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.2 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.1 |
GO:0010922 |
positive regulation of phosphatase activity(GO:0010922) |
| 0.0 |
0.8 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.6 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.2 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.1 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.0 |
0.2 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.1 |
GO:0061299 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.3 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.2 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
1.0 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.0 |
0.2 |
GO:0070901 |
mitochondrial tRNA methylation(GO:0070901) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.1 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.1 |
GO:0045686 |
negative regulation of glial cell differentiation(GO:0045686) negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 |
0.2 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 |
0.1 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.0 |
0.3 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.1 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.0 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.1 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
0.1 |
GO:0006721 |
terpenoid metabolic process(GO:0006721) |
| 0.0 |
0.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.2 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.3 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.0 |
0.1 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.9 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.5 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.0 |
0.1 |
GO:0002666 |
positive regulation of T cell tolerance induction(GO:0002666) |
| 0.0 |
0.2 |
GO:0070777 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.0 |
0.4 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.0 |
0.4 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 |
0.1 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.0 |
0.2 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.0 |
0.1 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
0.1 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.0 |
0.2 |
GO:0086027 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.0 |
0.6 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 |
0.1 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.0 |
0.2 |
GO:0046149 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 |
0.3 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.0 |
0.4 |
GO:1902222 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.1 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.0 |
0.4 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.0 |
0.1 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.0 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.6 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.2 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.0 |
0.4 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.2 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.0 |
2.2 |
GO:0044243 |
multicellular organism catabolic process(GO:0044243) |
| 0.0 |
0.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.0 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.0 |
GO:0043368 |
positive T cell selection(GO:0043368) |
| 0.0 |
0.2 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.3 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.5 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.4 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.1 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.0 |
0.3 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.0 |
0.0 |
GO:0009804 |
coumarin metabolic process(GO:0009804) |
| 0.0 |
0.1 |
GO:0097065 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.0 |
0.1 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.0 |
0.2 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.2 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.0 |
0.2 |
GO:0002441 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.1 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 0.0 |
0.4 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.0 |
0.1 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.0 |
0.1 |
GO:0042435 |
serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.0 |
0.8 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.0 |
0.1 |
GO:0042089 |
cytokine biosynthetic process(GO:0042089) |
| 0.0 |
0.1 |
GO:2000377 |
regulation of reactive oxygen species metabolic process(GO:2000377) |
| 0.0 |
0.2 |
GO:1903358 |
regulation of Golgi organization(GO:1903358) |
| 0.0 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.0 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.2 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.2 |
GO:0035655 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.0 |
0.1 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.1 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.0 |
0.1 |
GO:1904587 |
response to glycoprotein(GO:1904587) |
| 0.0 |
0.0 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.1 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.0 |
0.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.0 |
GO:0043396 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.0 |
0.1 |
GO:0044728 |
DNA methylation or demethylation(GO:0044728) |
| 0.0 |
0.3 |
GO:1903959 |
regulation of anion transmembrane transport(GO:1903959) |
| 0.0 |
0.1 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.0 |
0.5 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.4 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.0 |
0.8 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
1.2 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.5 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.4 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.6 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 |
0.1 |
GO:0046098 |
guanine catabolic process(GO:0006147) guanine metabolic process(GO:0046098) |
| 0.0 |
0.5 |
GO:0044550 |
secondary metabolite biosynthetic process(GO:0044550) |
| 0.0 |
0.1 |
GO:0031128 |
developmental induction(GO:0031128) |
| 0.0 |
0.2 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.4 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.0 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.1 |
GO:0009744 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.2 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.4 |
GO:1900744 |
regulation of p38MAPK cascade(GO:1900744) |
| 0.0 |
0.0 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.6 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.0 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.0 |
0.1 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.0 |
0.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.3 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.0 |
0.1 |
GO:0060051 |
negative regulation of protein ADP-ribosylation(GO:0010836) negative regulation of protein glycosylation(GO:0060051) |
| 0.0 |
0.2 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.1 |
GO:0009593 |
detection of calcium ion(GO:0005513) detection of chemical stimulus(GO:0009593) |
| 0.0 |
0.5 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 |
2.1 |
GO:0050911 |
detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 |
0.1 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.0 |
0.2 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.0 |
0.2 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.0 |
0.1 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.0 |
0.2 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.3 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.1 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.0 |
0.1 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 |
0.2 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.0 |
0.2 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.0 |
0.5 |
GO:0090662 |
ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.2 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.3 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.0 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.0 |
0.2 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.0 |
GO:0007595 |
lactation(GO:0007595) |
| 0.0 |
0.1 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.0 |
0.4 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.0 |
0.1 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.0 |
0.3 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.0 |
0.4 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.0 |
0.1 |
GO:2001244 |
positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 |
0.1 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.0 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.0 |
2.1 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.1 |
GO:0060380 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.0 |
0.1 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.0 |
GO:0009726 |
detection of endogenous stimulus(GO:0009726) |
| 0.0 |
0.1 |
GO:0030638 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 |
0.1 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 |
0.2 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.4 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 |
0.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.0 |
0.1 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 |
0.1 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.0 |
0.2 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.1 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.4 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.0 |
GO:0050905 |
neuromuscular process(GO:0050905) |
| 0.0 |
0.4 |
GO:0022404 |
hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
| 0.0 |
0.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.1 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.1 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.0 |
0.1 |
GO:0035307 |
positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.0 |
0.0 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.1 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.2 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.0 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.0 |
0.1 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.0 |
0.0 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 |
0.0 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.0 |
0.1 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
0.1 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 |
0.4 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.5 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.5 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.2 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.0 |
0.0 |
GO:0021722 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.0 |
0.3 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 |
0.2 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.0 |
0.0 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.0 |
0.1 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.0 |
0.3 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 |
0.6 |
GO:0038202 |
TORC1 signaling(GO:0038202) |
| 0.0 |
0.0 |
GO:0009624 |
response to nematode(GO:0009624) |
| 0.0 |
0.0 |
GO:0035935 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.0 |
0.2 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.0 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
0.0 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.6 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.1 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 |
0.2 |
GO:0072512 |
ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.0 |
0.0 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.1 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.0 |
0.3 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.1 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
0.0 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.0 |
GO:0045416 |
positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.0 |
0.1 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
0.0 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.0 |
GO:0043616 |
regulation of keratinocyte proliferation(GO:0010837) keratinocyte proliferation(GO:0043616) |
| 0.0 |
0.2 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.0 |
0.0 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.0 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.0 |
0.1 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.0 |
0.0 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 |
0.0 |
GO:0021780 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.2 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.0 |
0.1 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.0 |
0.0 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.0 |
0.1 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.0 |
0.4 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.1 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.0 |
0.1 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.1 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 |
0.1 |
GO:0033005 |
positive regulation of mast cell activation(GO:0033005) |
| 0.0 |
0.0 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.0 |
0.1 |
GO:1901186 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.0 |
0.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
0.1 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.0 |
0.0 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 |
0.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
0.0 |
GO:0030879 |
mammary gland development(GO:0030879) |
